Αρχική World News Veteran Drops To The Ground When He Hears How Much His Untouched...

Veteran Drops To The Ground When He Hears How Much His Untouched Watch Is Worth

A US Air Force veteran is reeling from the appraisal he received for a watch he purchased while in the military.The man joined the Air Force in 1971. His draft number was 7, which meant that he was pretty much guaranteed to see combat over I Vietnam. When he wasn’t clearing roads of land mines and disarming the enemy’s munitions he spent time flying between bases on Air America Airlines. The pilots that were flying those planes at the time wore Rolex watches.“I was intrigued by them,” the veteran tells the host of Antiques Roadshow. “I always wanted to purchase one, but they were very expensive.”Source: YouTube/Antiques Roadshow PBS
A US Air Force veteran brought his Rolex watch on Antiques Roadshow.


The veteran was later transferred to another base where he got into scuba diving. Understanding that Rolex watches were prized among scuba divers, too, he eventually found one that was within his price range. For the discounted price of $345.97, still more than his monthly salary, he ordered it through a catalog, but never took it diving. It seemed like too nice a piece to wear in the ocean.“I just kept it,” he says. “After I got out of the service, I woree some other watches and put this one in a safety deposit box.”Source: YouTube/Antiques Roadshow PBS
The watch has never been worn.


The watch stayed there for 30 or 40 years, only being taken out twice to be examined, then put back.Along with the watch, in pristine condition, the veteran saved all the documents that came with it, the guarantee, left blank, the brochure, receipts and all.For the blank guarantee card alone, the appraiser says the veteran could find someone willing to pay as much as $2,000.“It could be made to match any watch and add value to it.” He says. “Guys would pay money to buy a blank paper.”Source: YouTube/Antiques Roadshow PBS
When the veteran heard how much his watch was worth, he collapsed.


The appraiser goes over the watch’s finest details. He tells the veteran that this particular watch is so prized because it resembles one Paul Newman wore in the movie, “Winning,” though even Newman’s was a cheaper version of the rare Oyster. Those watches sell at auction for as much as $150,000 to $200,000.That’s where the veteran squints in disbelief.“You’re watch is more special,” the appraiser continues. “A watch like this, at auction, is worth about $400,000.”Source: YouTube/Antiques Roadshow PBS
The veteran could make as much as $700,000 from the Rolex.


The veteran immediately collapses to the ground.Because the watch was never worn, the appraiser actually believes it’s worth closer to $500,000 to $700,000.“You’ve gotta be [expletive] kidding me!” The veteran chuckles.Source: YouTube/Antiques Roadshow PBS
He’s happy with the appraisal!
“No, I am very serious,” the appraiser reassures. “I can’t thank you enough for bringing me one of the greatest watches I’ve ever seen on Antiques Roadshow, and thank you very much for your service.”Watch the exciting reveal in the video below.Proper BCS greatergood_ctg_abovevideoSource

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

Overall Breast Cancer Incidence Down Since 1999, Rates Increase for Women Under 40

U.S. breast cancer death rates decreased by about 1% per year between 2013 and 2018. What were the new case rates during that same...

Impressive Responses to PD-1 Blockade in a Large Cohort of Children and Young Adults with Recurrent/Progressive Germline DNA Replication Repair-Deficient Cancers

A large, observational, registry-based study that leveraged systematically collected data gathered both retrospectively and prospectively through the International Replication Repair Deficiency Consortium reveals impressive...

2-Year-Boy Is So Excited To See Himself In Disney’s ‘Encanto’

The importance of representation in media has been a growing topic of concern, and companies have responded by adding more diversity to their characters,...

Man Walks Entire Continent To Spread Awareness About Mental Health & Suicide Prevention

Matthew Fennell is walking over 3,000 miles across Australia for an important cause and one that is near and dear to his heart. Last year,...

Boy Battling Cancer Becomes Honorary Police Officer, Sworn In To 45 Agencies

At just ten years old, Devarjaye “DJ” Daniel has already been through more than most people go through in their entire lives. DJ has been...

Paclitaxel and Carboplatin Not Inferior When Compared with Paclitaxel and Ifosfamide for the Treatment of Patients with Uterine Carcinosarcoma

With regard to overall survival (OS), paclitaxel and carboplatin was not inferior and demonstrated improved progression-free survival (PFS) when compared with paclitaxel and ifosfamide...